Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
369.84
-1.53 (-0.41%)
At close: Aug 15, 2025, 4:00 PM
345.50
-24.34 (-6.58%)
After-hours: Aug 15, 2025, 7:59 PM EDT
Madrigal Pharmaceuticals Employees
Madrigal Pharmaceuticals had 528 employees as of December 31, 2024. The number of employees increased by 152 or 40.43% compared to the previous year.
Employees
528
Change (1Y)
152
Growth (1Y)
40.43%
Revenue / Employee
$976,415
Profits / Employee
-$533,900
Market Cap
8.24B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 528 | 152 | 40.43% |
Dec 31, 2023 | 376 | 284 | 308.70% |
Dec 31, 2022 | 92 | 21 | 29.58% |
Dec 31, 2021 | 71 | 29 | 69.05% |
Dec 31, 2020 | 42 | 13 | 44.83% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MDGL News
- 10 hours ago - Madrigal Pharmaceuticals: A High-Paced Launch That Could Grow Further - Seeking Alpha
- 4 days ago - Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewsWire
- 8 days ago - Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Madrigal Pharmaceuticals Reports Second-Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
- 15 days ago - Madrigal Pharmaceuticals: Rezdiffra Expansion Avenues Shift Focus To Long Term - Seeking Alpha
- 16 days ago - Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited - GlobeNewsWire
- 21 days ago - Madrigal Pharmaceuticals to Release Second-Quarter 2025 Financial Results and Host Webcast on August 5, 2025 - GlobeNewsWire